Pro Share Advisors LLC Kura Oncology, Inc. Transaction History
Pro Share Advisors LLC
- $46.4 Billion
- Q3 2025
A detailed history of Pro Share Advisors LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 16,880 shares of KURA stock, worth $189,056. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,880
Previous 19,449
13.21%
Holding current value
$189,056
Previous $112,000
33.04%
% of portfolio
0.0%
Previous 0.0%
Shares
32 transactions
Others Institutions Holding KURA
# of Institutions
213Shares Held
81.2MCall Options Held
900KPut Options Held
228K-
Bvf Inc San Francisco, CA8.62MShares$96.5 Million4.13% of portfolio
-
Suvretta Capital Management, LLC New York, NY8.12MShares$90.9 Million2.16% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$78 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.47MShares$61.2 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY4.67MShares$52.3 Million0.64% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $749M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...